EXAC Exactech, Inc.

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Exactech (EXAC) on Behalf of Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--

Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Exactech, Inc. (NASDAQ:EXAC) stockholders concerning the proposed acquisition of the company by TPG Capital.

Our investigation concerns whether Exactech’s board of directors failed to adequately shop the Company and obtain the best possible value for its stockholders before entering into a definitive merger agreement with TPG Capital. Under the terms of the agreement, Exactech unitholders will receive $42, in cash, for each Exactech share they hold. Exactech founders Dr. Bill Petty and Betty Petty, and CEO David Petty have agreed with TPG to vote all of their shares in favor of the merger and to exchange a significant portion of their shares for new shares in the parent entity immediately following the merger.

If you own Exactech shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation of Exactech, Inc., please go to http://www.bespc.com/exactech. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.

EN
25/10/2017

Underlying

EXACExactech, Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Exactech, Inc.

 PRESS RELEASE
Free
EXAC EXACTECH
INC.

Exactech Announces Completion of Merger with TPG Capital

GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, is pleased to announce the successful completion of the previously announced merger agreement with TPG Capital, pursuant to which TPG has acquired all of the issued and outstanding common stock of Exactech. In connection with the transaction, Exactech shareholders will receive $49.25 in cash for each share of Exactech common stock they hold (o...

February 14, 2018 1 EN
 PRESS RELEASE
Free
EXAC EXACTECH
INC.

Exactech Shareholders Approve Merger Agreement with TPG Capital

GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, today announced that at a Special Meeting of Shareholders held earlier today, Exactech’s shareholders approved the previously announced merger agreement with TPG Capital and certain of its affiliates, and approved the other two proposals described in Exactech’s proxy statement relating to today’s meeting. Approximately 94.5% of voting Exact...

February 13, 2018 1 EN
 PRESS RELEASE
Free
EXAC EXACTECH
INC.

EXACTECH (EXAC) INVESTOR ALERT - Andrews & Springer LLC is Seeking Mor...

WILMINGTON, Del.--(BUSINESS WIRE)-- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Exactech, Inc. (NASDAQGS: EXAC) (“Exactech” or the “Company”) relating to the sale of the Company to affiliates of private equity firm TPG Capital (“TPG”). On December 4, 2017, the two parties announced the signing of an amended merger agreement pursuant to which TPG will acquire Exacte...

December 21, 2017 1 EN
 PRESS RELEASE
Free
EXAC EXACTECH
INC.

EXACTECH (EXAC) SHAREHOLDER ALERT - Andrews & Springer LLC is Seeking ...

WILMINGTON, Del.--(BUSINESS WIRE)-- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Exactech, Inc. (NASDAQGS: EXAC) (“Exactech” or the “Company”) relating to the sale of the Company to affiliates of private equity firm TPG Capital (“TPG”). On December 4, 2017, the two parties announced the signing of an amended merger agreement pursuant to which TPG will acquire Exacte...

December 14, 2017 1 EN
 PRESS RELEASE
Free
EXAC EXACTECH
INC.

Exactech Announces Successful First Surgery with Vantage ® Total Ankl...

GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, hip, and knee, announced today the successful first surgery using its new Vantage® Total Ankle Mobile Bearing System, the newest addition to the Exactech extremities product line. Orthopaedic surgeon and Vantage Ankle design team member Professor Victor Valderrabano, MD, PhD, chairman of the Swiss Ortho Center Basel, recently performed the first case in the world with the mobile, ...

December 7, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch